Encyclopedia of Cancer
Academic Press
3rd Edition
Published on 28. December 2018
Book
1841 pages
978-0-12-812484-0 (ISBN)
Description
Encyclopedia of Cancer, Third Edition, Three Volume Set provides a comprehensive, up-to-date overview of the multiple facets of the disease, including research, treatment and societal impact. This new edition comprises 180 contributions from renown experts who present the latest in Mechanisms, Hallmarks of Cancer, Causes of Cancer, Prevention and Control, Diagnosis and Therapy, Pathology and the Genetics of specific Cancers. Readers will find a comprehensive overview of the main areas of oncology, including etiology, mechanisms, prevention, and treatments, from basic science to clinical applications and public health, all set alongside the latest advances and hot topics that have emerged since the previous edition.
Topics of interest in the field, including genomics and epigenomics, our understanding of the causes of cancer and the approaches to preventing it (e.g., HPV vaccination, role of obesity and nutrition, molecular markers of environmental exposures), new screening techniques (e.g., low-dose CT for lung cancer) and improvements in the treatment of many cancers (e.g., breast cancer, lung adenocarcinoma) are comprehensively and authoritatively presented.
Topics of interest in the field, including genomics and epigenomics, our understanding of the causes of cancer and the approaches to preventing it (e.g., HPV vaccination, role of obesity and nutrition, molecular markers of environmental exposures), new screening techniques (e.g., low-dose CT for lung cancer) and improvements in the treatment of many cancers (e.g., breast cancer, lung adenocarcinoma) are comprehensively and authoritatively presented.
More details
Edition
3rd edition
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
The encyclopedia is an essential resource for Oncologists; cancer researchers; oncology fellows in training; students and researchers in biology and epidemiology. Because of the breadth and depth of the work, medical doctors other than oncologists and other cancer-related medical professionals will also benefit.
Dimensions
Height: 276 mm
Width: 216 mm
Weight
7200 gr
ISBN-13
978-0-12-812484-0 (9780128124840)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Previous edition
Book
07/2002
2nd Edition
Academic Press
€1,859.45
Withdrawn from sale
Persons
Dr. Boffetta moved to Mount Sinai School of Medicine in 2010. He is Associate Director for Population Sciences of The Tisch Cancer Institute and Chief of the Division of Cancer Prevention and Control of the Department of Oncological Sciences. He is also the Bluhdorn Professor of International Community Medicine.
Dr. Boffetta is Adjunct Professor at the Harvard School of Public Health (Boston, MA), Vanderbilt University (Nashville, TN), and the Catholic University of Rome (Italy). He is also Affiliate Member of the R. Samuel McLaughlin Centre for Population Health Risk Assessment, University of Ottawa (Ottawa, Canada), and Senior Fellow of the Hellenic Health Foundation (Athens, Greece).
H-index 99; 1134 documents; publication range 1987 - present; over 150 co-authors; 42,863 citations in 29,080 documents Pierre Hainaut (born 1958, Belgium) is PhD in Biology, University of Liege, Belgium, 1987. After postdocs in France and in the UK (1988-1994), he joined the International Agency for Research on Cancer (IARC, World Health Organization) in 1994, where he held the post of head of Molecular Carcinogenesis from 1999 to 2011. In 2012, he joined the International Prevention Research Institute as Research Director. Since 2014, has been appointed as Professor of Cancer Biology and Chair of Excellence in Translational Research at Universite Grenoble Alpes, France. Since October 2014, he is Director of the Institute of Advanced Biosciences (formerly Institut Albert Bonniot), a multi-thematic research center supported dedicated to Epigenetics, Chronic Diseases and Cancer (17 research teams). His research focuses on TP53 mutations and on biomarkers of transition from chronic diseases to cancer. From 1994 to 2011, he has led the development of the international IARC database of TP53 mutations, a source of information on the causes and consequences of mutations affecting the p53 suppressor protein in cancer. His current research focuses on gain-of-function effects in lung cancer and on biomarkers for early detection of liver and lung cancers, in particular in low-resource countries. Pierre Hainaut is author of over 400 publications and 50 book chapters (h index: 72, Google Scholar). He has co-edited two books on p53 ("25 Years of p53 Research? 2005, 2007, "p53 in the Clinics?, Springer) and a textbook of Molecular Epidemiology ("Molecular Epidemiology: Principle and Practice?, IARC Press, 2011).
Dr. Boffetta is Adjunct Professor at the Harvard School of Public Health (Boston, MA), Vanderbilt University (Nashville, TN), and the Catholic University of Rome (Italy). He is also Affiliate Member of the R. Samuel McLaughlin Centre for Population Health Risk Assessment, University of Ottawa (Ottawa, Canada), and Senior Fellow of the Hellenic Health Foundation (Athens, Greece).
H-index 99; 1134 documents; publication range 1987 - present; over 150 co-authors; 42,863 citations in 29,080 documents Pierre Hainaut (born 1958, Belgium) is PhD in Biology, University of Liege, Belgium, 1987. After postdocs in France and in the UK (1988-1994), he joined the International Agency for Research on Cancer (IARC, World Health Organization) in 1994, where he held the post of head of Molecular Carcinogenesis from 1999 to 2011. In 2012, he joined the International Prevention Research Institute as Research Director. Since 2014, has been appointed as Professor of Cancer Biology and Chair of Excellence in Translational Research at Universite Grenoble Alpes, France. Since October 2014, he is Director of the Institute of Advanced Biosciences (formerly Institut Albert Bonniot), a multi-thematic research center supported dedicated to Epigenetics, Chronic Diseases and Cancer (17 research teams). His research focuses on TP53 mutations and on biomarkers of transition from chronic diseases to cancer. From 1994 to 2011, he has led the development of the international IARC database of TP53 mutations, a source of information on the causes and consequences of mutations affecting the p53 suppressor protein in cancer. His current research focuses on gain-of-function effects in lung cancer and on biomarkers for early detection of liver and lung cancers, in particular in low-resource countries. Pierre Hainaut is author of over 400 publications and 50 book chapters (h index: 72, Google Scholar). He has co-edited two books on p53 ("25 Years of p53 Research? 2005, 2007, "p53 in the Clinics?, Springer) and a textbook of Molecular Epidemiology ("Molecular Epidemiology: Principle and Practice?, IARC Press, 2011).
Content
Mechanisms (edited by Gerd Pfeifer)
Hallmarks of Cancer (edited by Marco Pierotti)
Causes of Cancer (edited by Graham A. Colditz)
Prevention and Control (edited by Carlo La Vecchia)
Diagnosis and Therapy (edited by Marco Pierotti and Thomas Tursz)
Pathology and Genetics of Specific Cancers (edited by Fred Bosman)
Hallmarks of Cancer (edited by Marco Pierotti)
Causes of Cancer (edited by Graham A. Colditz)
Prevention and Control (edited by Carlo La Vecchia)
Diagnosis and Therapy (edited by Marco Pierotti and Thomas Tursz)
Pathology and Genetics of Specific Cancers (edited by Fred Bosman)